A. De Luca

Molecular Biology · 2006–2013

A researcher in the Science corpus: 4 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom A. De Luca trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Engelman
  2. L. Romani
  3. T. Yuan
  4. Lewis C. Cantley
  5. Julian Downward
  6. Joseph Schlessinger
  7. William Pao

Papers from A. De Luca's perspective

Ordered by how strongly the researchers A. De Luca trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Mutations of the BRAF gene in human cancer (Nature)
  2. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (Nature Cell Biology)
  3. The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins (Journal of Cell Biology)
  4. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism (Nature reviews genetics)
  5. Ras, PI(3)K and mTOR signalling controls tumour cell growth (Nature)
  6. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. (Proceedings of the National Academy of Sciences of the United States of America)
  7. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells (Nature Immunology)
  8. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. (Journal of Clinical Investigation)
  9. Targeting RAS signalling pathways in cancer therapy (Nature Reviews. Cancer)
  10. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. (Cancer Research)

Their papers